N-acetylneuraminic acid has great demand potential and good investment prospects

N-acetylneuraminic acid (Neu5Ac), also known as sialic acid, is an acetylated derivative of acidic glyconeuraminic acid. The chemical name is 5-amino-3,5-dideoxy-D-glycerol-D-galactononulose, its CAS number is 131-48-6, and its molecular formula is C₁₁H₁₉NO₉, the molecular weight is 309.27, and it is white crystal in general state.

N-acetylneuraminic acid (SA) products are divided into three types: food grade, pharmaceutical grade, and cosmetic grade. In 2017, Europe, the United States, and China successively issued regulations on the application of N-acetylneuraminic acid (SA) in infant formula foods and nutritional and health foods, promoting the rapid development of the global N-acetylneuraminic acid (SA) industry. Among them, food-grade N-acetylneuraminic acid (SA) dominates the world, with a market share of more than 95%. In 2022, as domestic and foreign companies attach importance to cosmetic-grade N-acetylneuraminic acid (SA), the cosmetic-grade market share will begin to grow significantly. In 2022, the production market shares of food-grade, pharmaceutical-grade, and cosmetic-grade N-acetylneuraminic acid (SA) will be 95.17%, 3.20%, and 1.63% respectively.

The technology development and product production of N-acetylneuraminic acid (SA) are technology-intensive industries with high technical and financial thresholds. Leading companies in this field mostly apply for patents on their technology and processes, restricting latecomer companies from entering the N-acetylneuraminic acid (SA) market. The downstream of N-acetylneuraminic acid (SA) is mainly used in food, cosmetics, medicine and other fields. Its application needs to be approved by relevant departments in various countries. In addition, the application time of N-acetylneuraminic acid (SA) is short and the product price is high. , resulting in a limited market size that is not enough to accommodate too many N-acetylneuraminic acid (SA) companies. The above factors have resulted in fewer N-acetylneuraminic acid (SA) manufacturing companies in the world, and they are mainly concentrated in Europe, China and other regions with strong industrialization strength and large downstream product markets.

China’s N-acetylneuraminic acid (SA) industry started late, with relatively few companies and a small industry scale. And these companies are mainly distributed in East China, South China, Central China, and West China. Specifically, Jiabiyou Biotechnology (Wuhan) Co., Ltd., which has the largest domestic production of N-acetylneuraminic acid (SA), is located in Wuhan, Hubei; Zhongke Hongji Biotechnology Co., Ltd. is located in Pingyao, Shanxi; Yuyao Lafus This Health Technology Co., Ltd. is located in Yuyao, Zhejiang; the production bases of Wuxi Aikepai Biotechnology Co., Ltd. and Guangzhou Junkang Biotechnology Co., Ltd. are located in Wuxi, Jiangsu and Guangzhou, Guangdong respectively. According to the“2023-2028 N-acetylneuraminic acid (SA) industry market supply and demand status and industry operating indicators in-depth investigation and analysis report” released by the Industrial Research Center strong> It shows that in 2022, China’s N-acetylneuraminic acid (SA) production will be 28 tons.